Abstract:Objective: Sepsis is an uncontrolled inflamatory response that occurs in the body towards infection. It’s an important clinical picture that is seen in high morbidity and mortality so early diagnose and treatment areimportant. For that reason, for the septic cases to get early diagnosis and to predict the prognosis, new biomarkers are needed nowadays. Presepsin, angiopoietin 1 and angiopoietin II are biomarkers that are not usedroutinely yet, in our study, according to the new description given in Sepsis 3 meeting, in cases that are diagnosed with sepsis, we aimed at comparing diagnostic and prognostic values of these biomarkers. Methods: In our study, there were two groups. Patient group consisting of 48 cases with 33 men and 15 women and control group consisting of 42 cases with 23 men and 19 women. Control group is selected within patient relatives with similarities of age and sex. Demographic datas, accompanying diseases, APACHE II, SAPS and SOFA scores counted in the first 24 hours, leukocyte count, eritrocyte sedimentation rate, C-reactive protein, procalcitonin value, culture sampling results (blood, urine, sputum, endotracheal aspirate) that are measured in their stays, 7th and 28th day mortality counts after their ICU stays are written down. Presepsin, angiopoietin I and angiopoietin II are detected by sandwich ELISA method. Results: According to demographic features there isn’t any significant statistical difference between the patient group and the control group (p>0.005). In patient group Presepsin, angiopoietin I and angiopoietin II values were statistically high significantly compared to the control group (p<0.001). After the evaluation, serumpresepsin value noticed that has a diagnostic value in the diagnosis of sepsis (EAA: 0.74, 95%GA: 0.64–0.85, p<0.001). The suggested border value for this value is predicted as 0.47, 73%sensitivity and 62% specificity are determined. Serum angiopoietin I value noticed that has a diagnostic value in the diagnosis of sepsis (EAA: 0.80, 95%GA: 0.71–0.89, p<0.001). The suggested border value for this value is predicted as 178.24, 69% sensitivity and 69% specificity are determined. Serum angiopoietin II value noticed that has a diagnostic value in the diagnosis of sepsis (EAA: 0.89, 95% GA: 0.82–0.95, p<0.001). The suggested border value for this value is predicted as 77.56, 84% sensitivity and 83% specificity are determined. Conclusions: In our study, presepsin, angiopoietin I and angiopoietin II values are determined as statistically high according to healthy control group and are found successful with high sensitivity and specificity in diagnosing. Presepsin, angiopoietin I and angiopoietin II values in septic patients are found successful with high sensitivity and specificity at 7th and 28th days mortality prediction.

Diagnostic and Prognostic Values of Serum Selenoprotein P and Soluble St2 Levels in Pulmonary Embolism

Soluble ST2 as a Biomarker for Predicting Right Ventricular Dysfunction in Acute Pulmonary Embolism

IL-33/sST2 signaling pathway in pulmonary thromboembolism: A clinical observational study

The prognostic value of HALP score and sPESI in predicting in-hospital mortality in patients with pulmonary thromboembolism

Pleural effusion as an indicator of short term mortality in acute pulmonary embolism

A new biomarker in the diagnosis and prognosis of pulmonary thromboembolism: Serum profilin-1

Associação do Nível de ST2 Solúvel com Mortalidade em 6 Meses e/ou Hospitalização Recorrente Relacionada a Doenças Cardiovasculares em Embolia Pulmonar

Evaluation of soluble P‐selectin as a predictive biomarker in acute symptomatic pulmonary embolism: Insights from a prospective observational study

Prognostic Impact of the Tricuspid Annular Plane Systolic Excursion/Pulmonary Arterial Systolic Pressure Ratio in Acute Pulmonary Embolism

Circulating Angiopoietin-2 (Angpt2) levels predict diagnosis of Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Eosinophil-to-Monocyte Ratio as a Candidate for a Novel Prognostic Marker in Acute Pulmonary Embolism: Is it a Consumptive Mechanism?

83 patients with pulmonary thromboembolism were retrospectively analyzed

Characteristics of patients with symptomatic and incidental pulmonary thromboembolism

Decreased Thrombin Generation is Associated with Increased Thrombin Generation Biomarkers and Blood Cellular Indices in Pulmonary Embolism

Soluble ST2 and mixed venous oxygen saturation for prediction of mortality in patients with pulmonary hypertension

The diagnostic significance of signal peptide-complement C1r/C1s, Uegf, and Bmp1-epidermal growth factor domain-containing protein-1 levels in pulmonary embolism

Predictors of chronic thromboembolic pulmonary hypertension in patients with submassive pulmonary embolism treated with catheter-directed thrombolysis versus anticoagulation alone: A secondary analysis of the SUNSET sPE trial

New Biomarker Candidates of Sepsis: Diagnostic and Prognostic Value of Presepsin, Angiopoietin 1 and 2

Soluble ST2 in Serum Predicts the Prognosis of Idiopathic Pulmonary Fibrosis: a Retrospective Study

Prognostic impact of pleural effusion in acute pulmonary embolism

Optimizing Use of High-Sensitivity Troponin for Risk-Stratification of Acute Pulmonary Embolism